During the “drugs, sex, and rock-and-roll era” in the 1970s, medical doctors at Princeton University proposed the idea of “postorgasmic illness syndrome”(POIS) which states a possible allergy towards masturbation, ejaculation, and even sex itself. “The salivia emitted from ejaculation can cause allergic reactions such as fatigue, sore throat, watery eyes, and even memory problems”, according to the doctors. Symptoms could last up to a week, similar to other allergic reactions.
Originally, the idea was dissed as “ludicrous” and “insignificant” having it affecting less than 1000 people in the United States. However, one Illinois resident named Thomas Steinberg was recently reported as, indeed, developing allergies to his own orgasms. “It’s terrible”, says Steinberg. “I can’t persue relationships or have the sexual desires that other guys my age get ot enjoy. It’s even difficult to pursue simply romantic relationships”.
Steinberg reports that he has attended numerous otolaryngologists and infectious disease specialists, but to no avail. The allergic reaction is so rare that even most medical professionals have paid little attention to the situation. “All that my doctors could conclude was that POIS has a correlation to ejaculations. I have been trying to abstain from any type of sexual interaction since”.
After conducting research, Steinberg found an OTC medication entitled Fexofenidine which provided antihistamines towards his sperm and other allergic triggers. Upon taking the meducaiton, Steinberg noted a 90% decrease in his allergic reactions, allowing him to pursue sex and orgasmic activity. Steinberg reports that his sexual pleasures “hopes to increase in the years to come”.
There is very little information provided about POIS. While it is a plausible assumption that it is caused by the sperm cells in semen, the allergy was still detected in individuals who are sterile. Throughout it’s history, fewer than 50 Americans have been diagnosed with POIS, though doctors plan to conduct more experiments with Fexofenidine to determine if it’s a reliable solution to rare allergy.